The average one-year price target for Structure Therapeutics Inc. - Depositary Receipt (NasdaqGM:GPCR) has been revised to $94.31 / share. This is an increase of 21.89% from the prior estimate of $77.37 dated December 3, 2025.
The price target is an average of many targets provided by analysts. The latest targets range from a low of $60.60 to a high of $131.25 / share. The average price target represents an increase of 45.23% from the latest reported closing price of $64.94 / share.
What is the Fund Sentiment?
There are 269 funds or institutions reporting positions in Structure Therapeutics Inc. - Depositary Receipt. This is an decrease of 32 owner(s) or 10.63% in the last quarter. Average portfolio weight of all funds dedicated to GPCR is 0.26%, an increase of 9.17%. Total shares owned by institutions decreased in the last three months by 0.93% to 66,389K shares.
The put/call ratio of GPCR is 0.60, indicating a bullish outlook.
What are Other Shareholders Doing?
Wellington Management Group Llp holds 5,689K shares. In its prior filing, the firm reported owning 6,876K shares , representing a decrease of 20.86%. The firm increased its portfolio allocation in GPCR by 7.73% over the last quarter.
Avoro Capital Advisors holds 5,156K shares. In its prior filing, the firm reported owning 0K shares , representing an increase of 100.00%.
Janus Henderson Group holds 4,449K shares. In its prior filing, the firm reported owning 4,573K shares , representing a decrease of 2.79%. The firm decreased its portfolio allocation in GPCR by 52.90% over the last quarter.
Deep Track Capital holds 4,216K shares. In its prior filing, the firm reported owning 5,134K shares , representing a decrease of 21.78%. The firm decreased its portfolio allocation in GPCR by 3.53% over the last quarter.
Bvf holds 3,204K shares. In its prior filing, the firm reported owning 1,771K shares , representing an increase of 44.71%. The firm increased its portfolio allocation in GPCR by 177.06% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.